ADJUCOR

AdjuCor is a high-tech medical device company that owns and is responsible for development, production, marketing and selling of a revolutionary technology for the treatment of end-stage heart failure patients. Its flagship product is called BEAT. The market introduction of BEAT will be the world’s first commercially available, minimal invasive application of mechanical circulatory support for the failing heart. It provides uni- or biventricular support, while also completely avoiding contact with blood. This unique feature set will allow for the transformation of standard-of-care treatment in end-stage heart failure, as well as greatly expand treatment to previously unreached patients.